1 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Filsuvez: new trials by email Literature Review of Filsuvez trials Research Report on Filsuvez
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex Filsuvez - Epidermolysis Bullosa Simplex | Phase 2 | Not yet recruiting | Stanford University | 10 | 2026-10-01 | 2026-08-10 |
| A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez Filsuvez - Epidermolysis Bullosa, Dystrophic, Epidermolysis Bullosa, Junctional | Recruiting | Chiesi Farmaceutici S.p.A. | 170 | 2024-12-18 | 2026-09-28 | |
| Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa Oleogel-S10, Control gel - Epidermolysis Bullosa | Phase 3 | Completed | Amryt Research Limited | 223 | 2017-03-29 | 2023-07-20 |
Epidermolysis Bullosa (1) · Epidermolysis Bullosa Dystrophica (1) · Epidermolysis Bullosa Simplex (1) · Epidermolysis Bullosa, Junctional (1)
Amryt Research Limited (1) · Chiesi Farmaceutici S.p.A. (1) · Stanford University (1)
United States (3) · France (2) · Germany (2) · Greece (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Chile (1) · Colombia (1) · Czechia (1) · Denmark (1) · Georgia (1)
Johannes S Kern, MD PhD (1) · Joyce Teng, MD, PhD, FAAD (1)
2016 (1)